PROGRESS OF DEVELOPMENT
Disclosuring of information after Phase 3
Drug | Dosage Form | Property | Indication | Status (Region) |
---|---|---|---|---|
Difluprednate | Eye drop | Corticosteroids | inflammation associated with ocular surgery, Uveitis | Approved (Russia) |
SJP-0132 | Eye drop | Novel mechanism of action | Dry eye | P3(Japan) |
SJP-0135 | Eye drop | Fixed combination | Glaucoma | P3(Japan) |
SJP-0008 | Oral tablet | Novel mechanism of action | Central Retinal Artery Occlusion (CRAO) | P3(Japan) |